Topical treatment with the vitamin D analogue calcipotriol enhances the upregulation of the antimicrobial protein hCAP18/LL-37 during wounding in human skin in vivo

Experimental Dermatology

Volumn 19, Issue 4, 2010, Pages 332-338

  Heilborn, Johan D ^a   Weber, Günther ^a,b   Grönberg, Alvar ^a,c   Dieterich, Christine ^a,c   Ståhle, Mona ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITÉ DE TOURS   (France)

^c Lipopeptide AB   (Sweden)

Author keywords

Cathelicidin; LL 37; Skin; Vitamin D; Wound healing

Indexed keywords

CALCIPOTRIOL; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; MESSENGER RNA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPRESSION BANDAGE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; HUMAN; HUMAN TISSUE; IN VIVO STUDY; MALE; SINGLE BLIND PROCEDURE; SKIN INJURY; SKIN ULCER; UPREGULATION; VITAMIN SUPPLEMENTATION; VOLUNTEER; WOUND DRESSING; WOUND HEALING;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; ADMINISTRATION, TOPICAL; ADULT; AGED; AGED, 80 AND OVER; ANTIMICROBIAL CATIONIC PEPTIDES; CALCITRIOL; DERMATOLOGIC AGENTS; FEMALE; HUMANS; LEG ULCER; MALE; MIDDLE AGED; SKIN; UP-REGULATION; VITAMIN D; WOUND HEALING; WOUNDS AND INJURIES; YOUNG ADULT;

EID: 77951706009     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2009.00997.x     Document Type: Article

References (48)

1. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002, 415:389-395.
2. Zanetti M. Cathelicidins, multifunctional peptides of the innate immunity. J Leukoc Biol 2004, 75:39-48.
3. Zanetti M, Gennaro R, Romeo D. Cathelicidins: a novel protein family with a common proregion and a variable C-terminal antimicrobial domain. FEBS Lett 1995, 374:1-5.
4. Gudmundsson G H, Agerberth B, Odeberg J, Bergman T, Olsson B, Salcedo R. The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes. Eur J Biochem 1996, 238:325-332.
5. Nizet V, Ohtake T, Lauth X. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 2001, 414:454-457.
6. Hancock R E, Diamond G. The role of cationic antimicrobial peptides in innate host defences. Trends Microbiol 2000, 8:402-410.
7. Yang D, Chen Q, Schmidt A P. LL-37, the neutrophil granule- and epithelial cell derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells. J Exp Med 2000, 192:1069-1074.
8. Niyonsaba F, Iwabuchi K, Someya A. A cathelicidin family of human antibacterial peptide LL-37 induces mast cell chemotaxis. Immunology 2002, 106:20-26.
9. Carretero M, Escamez M J, Garcia M. In vitro and in vivo wound healing-promoting activities of human cathelicidin LL-37. J Invest Dermatol 2008, 128:223-236.
10. Tjabringa G S, Aarbiou J, Ninaber D K. The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor. J Immunol 2003, 171:6690-6696.
11. Tokumaru S, Sayama K, Shirakata Y. Induction of keratinocyte migration via transactivation of the epidermal growth factor receptor by the antimicrobial peptide LL-37. J Immunol 2005, 175:4662-4668.
12. Agerberth B, Gunne H, Odeberg J, Kogner P, Boman H G, Gudmundsson G H. FALL-39, a putative human peptide antibiotic, is cysteine-free and expressed in bone marrow and testis. Proc Natl Acad Sci U S A 1995, 92:195-199.
13. Sørensen O, Arnljots K, Cowland J B, Bainton D F, Borregaard N. The human antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific granules in neutrophils. Blood 1997, 90:2796-2803.
14. Bals R, Wang X, Zasloff M, Wilson J M. The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. Proc Natl Acad Sci U S A 1998, 95:9541-9546.
15. Frohm Nilsson M, Sandstedt B, Sørensen O, Weber G, Borregaard N, Ståhle-Bäckdahl M. The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6. Infect Immun 1999, 67:2561-2566.
16. Hase K, Eckmann L, Leopard J D, Varki N, Kagnoff M F. Cell differentiation is a key determinant of cathelicidin LL-37/human cationic antimicrobial protein 18 expression by human colon epithelium. Infect Immun 2002, 70:953-963.
17. Andersson E, Sorensen O E, Frohm B, Borregaard N, Egesten A, Malm J. Isolation of human cationic antimicrobial protein-18 from seminal plasma and its association with prostasomes. Hum Reprod 2002, 17:2529-2534.
18. Murakami M, Ohtake T, Dorschner R A, Gallo R L. Cathelicidin antimicrobial peptides are expressed in salivary glands and saliva. J Dent Res 2002, 81:845-850.
19. Murakami M, Ohtake T, Dorschner R A, Schittek B, Garbe C, Gallo R L. Cathelicidin anti-microbial peptide expression in sweat, an innate defense system for the skin. J Invest Dermatol 2002, 119:1090-1095.
20. Armogida S A, Yannaras N M, Melton A L, Srivastava M D. Identification and quantification of innate immune system mediators in human breast milk. Allergy Asthma Proc 2004, 25:297-304.
21. Murakami M, Dorschner R A, Stern L J, Lin K H, Gallo R L. Expression and secretion of cathelicidin antimicrobial peptides in murine mammary glands and human milk. Pediatr Res 2005, 57:10-15.
22. Frohm M, Agerberth B, Ahangari G. The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J Biol Chem 1997, 272:15258-15263.
23. Dorschner R A, Pestonjamasp V K, Tamakuwala S. Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J Invest Dermatol 2001, 117:91-97.
24. Heilborn J D, Nilsson M F, Kratz G. The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium. J Invest Dermatol 2003, 120:379-389.
25. Shaykhiev R, Beisswenger C, Kaendler K. The human endogenous antibiotic LL-37 stimulates airway epithelial cell proliferation and wound closure. Am J Physiol Lung Cell Mol Physiol 2005, 289:L842-L848.
26. Sørensen O E, Cowland J B, Theilgaard-Monch K, Liu L, Ganz T, Borregaard N. Wound healing and expression of antimicrobial peptides/polypeptides in human keratinocytes, a consequence of common growth factors. J Immunol 2003, 170:5583-5589.
27. Schauber J, Svanholm C, Termen S. Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes: relevance of signalling pathways. Gut 2003, 52:735-741.
28. Zanetti M. The role of cathelicidins in innate host defenses of mammals. Antimicrobial Peptides in Human Health and Disease 2005, 15-50. Gallo R L. In, ed, Norfolk, Horizon Bioscience
29. Wang T T, Nestel F P, Bourdeau V. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 2004, 173:2909-2912.
30. Weber G, Heilborn J D, Chamorro Jimenez C I, Hammarsjö A, Törmä H, Ståhle M. Vitamin D induces the antimicrobial protein hCAP18 in human skin. J Invest Dermatol 2005, 124:1080-1082.
31. Gombart A F, Borregaard N, Koeffler H P. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J 2005, 19:1067-1077.
32. Bikle D D, Nemanic M K, Gee E, Elias P. 1,25-Dihydroxyvitamin D3 production by human keratinocytes. Kinetics and regulation. J Clin Invest 1986, 78:557-566.
33. Bikle D D, Nemanic M K, Whitney J O, Elias P W. Neonatal human foreskin keratinocytes produce 1,25-dihydroxyvitamin D3. Biochemistry 1986, 25:1545-1548.
34. Vantieghem K, Kissmeyer A M, De Haes P, Bouillon R, Segaert S. UVB-induced production of 1,25-dihydroxyvitamin D3 and vitamin D activity in human keratinocytes pretreated with a sterol delta7-reductase inhibitor. J Cell Biochem 2006, 98:81-92.
35. Schauber J, Dorschner R A, Coda A B. Injury enhances TLR2 function and antimicrobial peptide expression through a vitamin D-dependent mechanism. J Clin Invest 2007, 117:803-811.
36. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
37. Bradford M M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976, 72:248-254.
38. Schagger H, von Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 1987, 166:368-379.
39. Koczulla R, von Degenfeld G, Kupatt C. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J Clin Invest 2003, 111:1665-1672.
40. Erdag G, Morgan J R. Interleukin-1alpha and interleukin-6 enhance the antibacterial properties of cultured composite keratinocyte grafts. Ann Surg 2002, 235:113-124.
41. Liu P T, Stenger S, Li H. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006, 311:1770-1773.
42. Zasloff M. Fighting infections with vitamin D. Nat Med 2006, 12:388-390.
43. Mallbris L, Wiegleb Edström D, Sundblad L, Granath F, Ståhle M. UVB upregulates the antimicrobial protein hCAP18/LL-37 mRNA in human skin. J Invest Dermatol 2005, 125:1072-1074.
44. Zugel U, Steinmeyer A, May E, Lehmann M, Asadullah K. Immunomodulation by a novel, dissociated Vitamin D analogue. Exp Dermatol 2009, 18:619-627.
45. Hehenberger K, Hansson A. High glucose-induced growth factor resistance in human fibroblasts can be reversed by antioxidants and protein kinase C-inhibitors. Cell Biochem Funct 1997, 15:197-201.
46. Hehenberger K, Heilborn J D, Brismar K, Hansson A. Inhibited proliferation of fibroblasts derived from chronic diabetic wounds and normal dermal fibroblasts treated with high glucose is associated with increased formation of l-lactate. Wound Repair Regen 1998, 6:135-141.
47. Islam D, Bandholtz L, Nilsson J. Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator. Nat Med 2001, 7:180-185.
48. Ong P Y, Ohtake T, Brandt C. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 2002, 347:1151-1160.